CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $285,501
- in 7 filings, $286K under 10b5-1 plans
Net −$285,501. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Brumm Joshua T −$160K Chief Executive Officer sold 3% of stake
- McNeill Jonathan −$77K President and COO sold 3% of stake
- Pinkas Jan −$12K Chief Scientific Officer sold 3% of stake
- Im Ellie Eunkyung −$11K Chief Medical Officer sold 3% of stake
- Bispham Barbara Harlin −$11K See Remarks sold 3% of stake
Reading 48 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-22 | Goldberg Mark Alan Director | Grant or award · Stock Option (right to buy) | +21,000 | 21,000 | ||
| 2020-05-22 | Andrews Patricia S Director | Grant or award · Stock Option (right to buy) | +21,000 | 21,000 | ||
| 2020-03-09 | JUNIUS DANIEL M Director | Purchase | +20,000 | $3.40 | $68K | 38,000 |
| 2020-01-22 | Girard Armand SVP, Chief Business Officer | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2020-01-22 | Magnani John L. SVP of Research, CSO | Grant or award · Employee Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2020-01-22 | Hahn Brian M. SVP Finance, CFO | Grant or award · Employee Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2020-01-22 | Thackray Helen M. SVP Clinical Development, CMO | Grant or award · Employee Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2020-01-22 | King Rachel K. President, CEO | Grant or award · Employee Stock Option (right to buy) | +349,000 | 349,000 | ||
| 2020-01-06 | Magnani John L. SVP of Research, CSO | Option exercise | +106,983 | $1.12 | $120K | 289,760 |
| 2020-01-06 | Magnani John L. SVP of Research, CSO | Option exercise · Employee Stock Option (right to buy) | −106,983 | 0 | ||
| 2019-12-20 | Magnani John L. SVP of Research, CSO | Option exercise | +106,984 | $1.12 | $120K | 182,777 |
| 2019-12-20 | Magnani John L. SVP of Research, CSO | Option exercise · Employee Stock Option (right to buy) | −106,984 | 106,983 | ||
| 2019-09-05 | BVF PARTNERS L P/IL 10% owner | Purchase | +853,956 | $3.18 | $2.7M | 3,639,935 |
| 2019-09-05 | BVF PARTNERS L P/IL 10% owner | Purchase | +689,834 | $3.18 | $2.2M | 2,955,440 |
| 2019-09-05 | BVF PARTNERS L P/IL 10% owner | Purchase | +124,956 | $3.18 | $398K | 528,891 |
| 2019-08-13 | JUNIUS DANIEL M Director | Purchase | +10,000 | $3.18 | $32K | 18,000 |
| 2019-08-06 | King Rachel K. President, CEO | Option exercise | +166,759 | $1.12 | $187K | 307,144 |
| 2019-08-06 | King Rachel K. President, CEO | Option exercise · Employee Stock Option (right to buy) | −166,759 | 130,821 | ||
| 2019-05-17 | Andrews Patricia S Director | Grant or award · Stock Option (right to buy) | +21,000 | 21,000 | ||
| 2019-05-17 | JUNIUS DANIEL M Director | Grant or award · Stock Option (right to buy) | +21,000 | 21,000 |
Page 11 of 16 · 305 trades